Mozambique to start cholera vaccinations next week after cyclone

Mozambique will start a cholera vaccination campaign next week in areas ravaged by Cyclone Idai, the World Health Organisation (WHO) said on Thursday, after five confirmed cases were detected.

Germany warns of medical products shortage if Brexit chaotic: paper

Germany could face shortages of medical products by mid-April if Britain makes a chaotic withdrawal from the European Union, German business daily Handelsblatt said on Thursday, citing a letter by Health Minister Jens Spahn to the EU Commission.

U.S. jury says Bayer must pay $80 million to man in Roundup cancer trial

A U.S. jury on Wednesday awarded $80 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits.

U.S. judge blocks Medicaid work requirements in Kentucky, Arkansas

A federal judge on Wednesday overturned the Trump administration's approval of plans by Kentucky and Arkansas to impose work requirements on people seeking Medicaid health insurance benefits.

New Jersey jury finds J&J not liable in talc cancer trial; company settles three other cases

A New Jersey jury on Wednesday cleared Johnson & Johnson of liability in a lawsuit brought by a man who said that asbestos in the company's talcum powder products caused his mesothelioma.

Democrats pounce as Trump administration ratchets up attack on Obamacare

Top congressional Democrats on Tuesday attacked a legal move by the Trump administration to step up its assault on the Obamacare healthcare law, saying last November's elections showed Americans want them to protect the Affordable Care Act.

J&J settles three mesothelioma talc cases-plaintiffs' lawyer

Johnson & Johnson has settled three cases brought by plaintiffs who claimed asbestos in the company's talcum-based products caused mesothelioma, an attorney for the plaintiffs' said on Wednesday.

Novartis MS drug wins FDA's blessing amid scrutiny of $88,000 annual price

Novartis AG has won U.S. Food and Drug Administration approval for multiple sclerosis drug Mayzent as the Swiss company targets patients whose disease advances from intermittent attacks to a gradually worsening condition.

Dense breast notification laws tied to more screening, cancer diagnoses

(Reuters Health) - State laws requiring women with dense breasts to be told about the benefits of following up a mammogram with further tests are associated with higher rates of additional screening and more diagnoses for breast cancer, a U.S. study finds.

Amid ruined lives, Mozambique's cyclone survivors face cholera, diarrhea

Dozens of fragile patients poured into a clinic in the wrecked Mozambican port city of Beira on Wednesday, as the government said it had confirmed the first five cases of cholera in the wake of deadly Cyclone Idai.

Factbox: Cyclone Idai's death toll rises to 713, hundreds of thousands displaced

Hundreds of thousands of people are in need of food, water and shelter after Cyclone Idai battered Mozambique, Zimbabwe and Malawi.

Related Videos

Cardi B files for 'Okurrr' trademark

INSIGHT: Skydivers with sparklers dazzle LA

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS